This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Innovation in medical technology exists to improve patient outcomes, increase surgical efficiency and enhance patient safety. Infrequently, we see medical technology innovation of a paradigmatic nature that changes the way physicians approach disease states and dramatically improve results.
tim.hodson Wed, 03/12/2025 - 15:36 Broward Health recently announced it is now offering the Farapulse Pulsed Field Ablation System to treat atrial fibrillation (A-Fib). This innovative treatment represents a significant advancement over traditional thermal ablation methods and provides a more effective solution for patients.
milla1cf Mon, 01/08/2024 - 14:26 January 8, 2024 — Stereotaxis , a pioneer in surgical robotics for minimally invasive endovascular intervention, announced that the first patients have been successfully treated using its Magnetic Interventional Ablation Catheter, MAGiC. Physicians at Vilnius University.
a medical device company dedicated to advancing ablation treatment for cardiac arrythmias, announced its participation at the Heart Rhythm 2024 conference, taking place in person at the Boston Convention & Exhibition Center and virtually, May 16-19, 2024. milla1cf Wed, 05/15/2024 - 19:05 May 15, 2024 — CardioFocus, Inc. ,
milla1cf Thu, 01/18/2024 - 14:21 January 18, 2024 — Abbott announced the first global procedures have been conducted using the company's new Volt Pulsed Field Ablation (PFA) System to treat patients battling common abnormal heart rhythms such as atrial fibrillation (AFib).
Titled "Real-world Data Affirms Safety and Effectiveness of Low/Zero Fluoroscopy Atrial Fibrillation Ablation," the study was presented as a late-breaker at the 29th Annual International AF Symposium. Biosense Webster's zero fluoroscopy workflow is the first and only such workflow available in a radiofrequency (RF) cardiac ablation device.
Background Catheter ablation (CA) for symptomatic atrial fibrillation (AF) offers the best outcomes for patients. Despite the benefits of CA, a significant proportion of patients suffer a recurrence; hence, there is scope to potentially improve outcomes through technical innovations such as ablation index (AI) guidance during AF ablation.
tim.hodson Thu, 04/24/2025 - 09:52 April 24, 2025 The Heart Rhythm Society (HRS) and the American College of Cardiology (ACC) have released a scientific statement on new guiding principles for Same-Day Discharge (SDD) for patients undergoing intracardiac catheter ablation procedures. Jones, MD, MPH, FACC, FHRS, Co-Chair of the document.
tim.hodson Wed, 03/12/2025 - 15:36 Broward Health recently announced it is now offering the Farapulse Pulsed Field Ablation System to treat atrial fibrillation (A-Fib). This innovative treatment represents a significant advancement over traditional thermal ablation methods and provides a more effective solution for patients.
Background Cryoballoon ablation (CBA) and laser balloon ablation (LBA) are two innovative ways for the treatment of atrial fibrillation (AF). This study aimed to evaluate the efficacy and safety of cryoballoon ablation and laser balloon ablation in patients with AF.
Pulsed field ablation (PFA) has emerged as an innovative new ablation strategy for the treatment of AF. Little is known about the treatment of atypical atrial flutter that occurs after PFA of AF.
BackgroundCatheter ablation is frequently used to manage recurrent atrial fibrillation (AF) resistant to drug therapy, with pulmonary vein isolation (PVI) as a key tactic. The reconnection of pulmonary veins was discovered primarily in the anterior region of the right superior PV and the superior portion of the left superior PV.
PPMC, part of the University of Pennsylvania Health System, renowned for advanced clinical research, innovation, and compassionate patient care, stands at the forefront as the first in the Northeast United States to offer the Genesis System. We are committed to leveraging cutting-edge innovations to provide patients with the best care.
Stereotaxis will present an innovative proposal leveraging advanced robotic technology and telerobotic presence to sustainably offer high-quality cardiac ablation therapy in underserved regions of Africa. The latest innovation in the Stereotaxis robotic system allows it to be installed and maintained on a standard semi-trailer truck.
Pulsed field ablation (PFA) is an innovative non-thermal energy modality utilized for atrial fibrillation (AF) and atrial flutter ablation. Instances of coronary artery vasospasm have been reported but there are no known cases of thrombotic occlusion linked to PFA.
Pulsed field ablation (PFA) has emerged as an innovative technology for treating cardiac arrhythmias. Greater PFA energy may be necessary to ablate ventricular myocardium for ventricular tachycardia circuits, but this carries risks of side effects such as gaseous formation (microbubbles) and hemolysis.
Pulsed field ablation (PFA) is an innovative technique for managing atrial fibrillation (AF). Episodes of asystole of varying durations have been reported during electroporation, though the underlying mechanisms remain poorly understood.
Patients suffering from heart rhythm disorders are now being successfully treated with robotic ablation procedures using this advanced technology, and Hospital Santa Maria della Pietà is the first hospital in Italy to adopt the cutting-edge Genesis Robotic Magnetic Navigation (RMN) system.
Medtronic Creates History with FDA Approval of its Novel PulseSelect Pulsed Field Ablation System to Treat Atrial Fibrillation 3. Patients Implanted with Innovative FIRE1 Remote Heart Failure Monitoring System in Early Feasibility Study A Dietary Supplement Leads to Remarkable Regression in Atherosclerotic Lesions 2.
Pulsed-field ablation (PFA) has emerged as an innovative treatment for atrial fibrillation (AF), utilizing high-energy pulsed electric fields to induce tissue necrosis. Established thermal ablation modalities, such as radiofrequency (RF) and cryo-balloon (CB), report acute pericarditis rates ranging from 110%.
An innovative mapping and ablation catheter (Sphere-9TM, Medtronic) fully integrated into a novel mapping and ablation platform (AfferaTM, Medtronic) was introduced (1,2).
Infusion and uptake of calcium chloride during pulsed field ablation leads to greater irreversible electroporation and larger myocardial ablation lesions. Abstract Introduction Pulsed field ablation (PFA) has emerged as an innovative therapy for cardiac arrhythmias.
Stereotaxis’ MAGiC catheter is a robotically navigated magnetic ablation catheter designed to perform minimally invasive cardiac ablation procedures. The catheter is the first in a series of interventional devices being developed by Stereotaxis and serves as a platform for future innovations.
on the feasibility and efficacy of focal pulsed-field ablation (PFA) for creating an anterior mitral line (AML) in 19 patients.1 1 The authors are to be congratulated on their innovative study, which establishes a new foundation for deploying an AML using a different energy source. We read with great interest the paper by Wenzel et al.
Symptom-driven electrocardiogram (ECG) recording plays a significant role in the detection of post-ablation atrial fibrillation recurrence (AFR). The authors of an article published in Cardiovascular Innovations and Applications deployed a deep learning (DL)-based handheld device to facilitate symptom-driven monitoring.
a company primarily focused on leveraging its novel and proprietary CellFX Nanosecond Pulsed Field Ablation (nsPFA) technology for the treatment of atrial fibrillation, announced the completion of the first five procedures in its first-in-human feasibility study with its novel CellFX nsPFA cardiac catheter.
Pulsed field ablation (PFA) is an innovative technology recently adopted for treating atrial fibrillation (AF). Preclinical and clinical studies have reported a reassuring safety profile because of its tissue-specific effect, sparing adjacent tissues.1
ABSTRACT Background Pulsed-field ablation (PFA) is an innovative non-thermal method for arrhythmia treatment. PFA lesions were assessed by gross pathology, histology, and post-ablation voltage amplitude. The efficacy of various PFA configurations in relation to contact force (CF) has not been well-studied in vivo.
The adoption of the latest robotic magnetic navigation system represents our continued commitment to pursuing the innovative technologies and techniques that benefit our patients.” “For Due to the complexity of Lewis’s arrhythmia, Dr. Tomassoni recommended a cardiac ablation using the Stereotaxis RMN system.
It's with immense pride and joy that we reflect on the milestones and accomplishments achieved by our collective dedication to advancing medical education and innovation. As we celebrate the triumphs of 2023, let's gear up for the promising horizons ahead, where the pursuit of knowledge and innovation knows no bounds.
From advances in pharmacological treatments to innovative procedures like catheter ablation, the landscape of AFib treatment is continually evolving. The Role of Research and Innovation Ongoing research in AFib is uncovering new insights into the pathophysiology of the condition and leading to the development of novel therapies.
Abstract Introduction Pulsed field ablation (PFA) has emerged as an innovative technique for pulmonary vein isolation (PVI). Typically, a transeptal puncture (TSP) with a standard sheath precedes a switch to the larger diameter sheath in the left atrium.
Cryoablation (CRYO) is a novel catheter ablation technique for atrial fibrillation (AF). A study published in Cardiovascular Innovations and Applications explores whether CRYO influences the metabolic signature—a possibility not previously investigated.
Atrial fibrillation (AF) is critically influenced by the left atrial (LA) substrate, impacting both the initiation and maintenance of AF and the outcomes of ablation treatments.
It's with immense pride and joy that we reflect on the milestones and accomplishments achieved by our collective dedication to advancing medical education and innovation. As we celebrate the triumphs of 2023, let's gear up for the promising horizons ahead, where the pursuit of knowledge and innovation knows no bounds.
From advances in pharmacological treatments to innovative procedures like catheter ablation, the landscape of AFib treatment is continually evolving. The Role of Research and Innovation Ongoing research in AFib is uncovering new insights into the pathophysiology of the condition and leading to the development of novel therapies.
Additionally, this platform integrates parameters such as contact force measurement and ablation indexes for RF and PFA which have proven in preclinical studies to be critical for lesion creation. With this differentiated system, Biosense Webster is giving EPs the tools and information they need in real-time.
We’re also seeing cardiovascular AI expand from diagnostics/detection to more procedural use cases, including a growing number of EP ablation mapping products and even AI-enhanced cardiac implants. The post AI Clearances Surge, Cardio AI Share Declines appeared first on Cardiac Wire.
While , treating VTs with drugs is still a choice, permanent solutions by defining the VT circuit and ablating them, is the new norm. We must thank the technological innovators in the electro-anatomical mapping system, who are continuously upgrading and providing the best to us.
We’re also seeing cardiovascular AI continue to expand from diagnostics/detection to more procedural use cases, including new solutions for TAVR and ablation planning that were cleared in H1 2024.
Learn how to know when it's appropriate to break the rules, when to challenge your superiors, how to do so without endangering your career and how to foster learning and innovation among the ranks of people conditioned to follow orders.
In August, J&J’s Biosense Webster announced that six of its AFib ablation products (e.g. The company also brought on medtech robotics veteran Pablo Garcia as its new GM, who previously co-founded Verb Surgical, which became the foundation of J&J’s forthcoming Ottava robotics surgery platform.
Discussing further, Catheterization Laboratory, also called Cath Lab, is a medical examination room where angiogram, angioplasty, ablation, and implantation of pacemaker are carried out. Augmenting Soft Tissue Visualisation The Cath labs face some issues that innovators find challenging to resolve.
As ECG Excellence we are proud our CineECG technology was part of this innovation festival. Over the past 3 days cardiologists from all over the world met in New Orleans to learn and discuss the developments in technology and patient care. Today we focus on the results of Ramkumar Venkateswaran and Edward Gerstenfeld, both working in UCSF.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content